{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:25:59Z","timestamp":1787286359867,"version":"build-2736575974"},"reference-count":44,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Issues Mol. Biol.","CIMB"],"abstract":"<jats:p>Triple-negative breast cancer (TNBC) lacks effective targeted therapeutic strategies, and cisplatin resistance remains a major challenge in clinical treatment. This study aimed to investigate whether inorganic phosphate (Pi) influences cellular responses to cisplatin and to explore the potential molecular mechanisms involving RB1\u2013E2F signaling, DNA repair regulation, and oxidative stress. Clinical associations between serum biochemical parameters and tumor histologic grade were evaluated in 246 patients with invasive ductal carcinoma. Triple-negative breast cancer cell line (MDA-MB-231), estrogen receptor-positive breast cancer cell line (MCF-7), and non-tumorigenic breast epithelial cell line (MCF-10A) were treated with control, Pi, cisplatin, or Pi combined with cisplatin.. Cellular proliferation, cell-cycle distribution, DNA damage, intracellular reactive oxygen species (ROS), inflammatory responses, and transcriptomic alterations were assessed using functional assays and RNA sequencing-based analyses. Pi levels showed an inverse association with tumor grade. In MDA-MB-231 cells, Pi combined with cisplatin resulted in enhanced growth inhibition, increased DNA damage accumulation, elevated cellular ROS production, and activation of inflammatory responses compared with cisplatin alone. Transcriptomic analyses revealed alterations in RB1\u2013E2F-related transcriptional programs and reduced expression of DNA repair-associated gene sets. TCGA-BRCA analysis further indicated that elevated DNA repair pathway activity was associated with unfavorable survival outcomes. These findings suggest that Pi may modulate cisplatin responses through coordinated regulation of RB1\u2013E2F signaling, DNA repair capacity, and oxidative stress responses, providing a potential mechanistic basis for further investigation of phosphate-associated therapeutic strategies in TNBC.<\/jats:p>","DOI":"10.3390\/cimb48080839","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:12:11Z","timestamp":1787069531000},"page":"839","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inorganic Phosphate Is Associated with RB1\u2013E2F-Related Transcriptional and DNA Repair-Associated Changes Under Cisplatin Exposure in MDA-MB-231 Cells"],"prefix":"10.3390","volume":"48","author":[{"given":"Xiao","family":"Yang","sequence":"first","affiliation":[{"name":"Heilongjiang Provincial Key Laboratory of Infection and Immunity, Department of Microbiology, School of Basic Medical Sciences, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Heilongjiang Provincial Key Laboratory of Infection and Immunity, Department of Microbiology, School of Basic Medical Sciences, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Li","sequence":"additional","affiliation":[{"name":"Heilongjiang Provincial Key Laboratory of Infection and Immunity, Department of Microbiology, School of Basic Medical Sciences, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, School of Basic Medical Sciences, Harbin Medical University, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5177-1927","authenticated-orcid":false,"given":"Fengmin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Heilongjiang Provincial Key Laboratory of Infection and Immunity, Department of Microbiology, School of Basic Medical Sciences, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5900-5154","authenticated-orcid":false,"given":"Wuqi","family":"Song","sequence":"additional","affiliation":[{"name":"Heilongjiang Provincial Key Laboratory of Infection and Immunity, Department of Microbiology, School of Basic Medical Sciences, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150081, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1002\/cncr.25961","article-title":"Triple-negative breast cancer in Hispanic patients: High prevalence, poor prognosis, and association with menopausal status, body mass index, and parity","volume":"117","author":"Arce","year":"2011","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple-negative breast cancer therapy: Current and future perspectives (Review)","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","article-title":"Epidemiology of Triple-Negative Breast Cancer: A Review","volume":"27","author":"Howard","year":"2021","journal-title":"Cancer J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/cncr.25862","article-title":"Higher population-based incidence rates of triple-negative breast cancer among young African-American women: Implications for breast cancer screening recommendations","volume":"117","author":"Amirikia","year":"2011","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1200\/JGO.2016.005397","article-title":"Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis","volume":"2","author":"Sandhu","year":"2016","journal-title":"J. Glob. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ferrari, P., Scatena, C., Ghilli, M., Bargagna, I., Lorenzini, G., and Nicolini, A. (2022). Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031665"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s40001-022-00839-0","article-title":"Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: Meta-analysis","volume":"27","author":"Lin","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lee, J. (2023). Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC). J. Clin. Med., 12.","DOI":"10.3390\/jcm12041524"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1200\/JCO.2009.22.4725","article-title":"Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer","volume":"28","author":"Silver","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1080\/13543784.2022.2159805","article-title":"\u2018Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research\u2019","volume":"31","author":"Passalacqua","year":"2022","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.14740\/jocmr2365w","article-title":"Rapid Extensive Recurrence of Triple Negative Breast Cancer: Are Both Therapy and Cancer Biology the Culprit?","volume":"8","author":"Vyas","year":"2016","journal-title":"J. Clin. Med. Res."},{"key":"ref_12","unstructured":"Adams, M.N., Ashton, N.W., Paquet, N., O\u2019Byrne, K.J., and Richard, D.J. (2014). Mechanisms of cisplatin resistance: DNA repair and cellular implications. Advances in Drug Resistance Research, Nova Science Publishers, Inc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bph.13690","article-title":"Chemoresistant lung cancer stem cells display high DNA repair capability to remove cisplatin-induced DNA damage","volume":"174","author":"Yu","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s13402-016-0291-7","article-title":"The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells","volume":"39","author":"Chen","year":"2016","journal-title":"Cell. Oncol."},{"key":"ref_16","unstructured":"Curtin, N.J., and Sharma, R.A. (2015). Disruption of DNA Repair by Cell Cycle and Transcriptional CDK Inhibition. PARP Inhibitors for Cancer Therapy, Springer International Publishing."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Manickavinayaham, S., Dennehey, B.K., and Johnson, D.G. (2021). Direct Regulation of DNA Repair by E2F and RB in Mammals and Plants: Core Function or Convergent Evolution?. Cancers, 13.","DOI":"10.3390\/cancers13050934"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Broeker, C., and Andrechek, E. (2022). E2F Transcription Factors in Cancer, More than the Cell Cycle. Comprehensive Pharmacology, Elsevier.","DOI":"10.1016\/B978-0-12-820472-6.00102-X"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00424-018-2231-z","article-title":"Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi)","volume":"471","author":"Jacquillet","year":"2019","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00223-019-00636-8","article-title":"Phosphate as a Signaling Molecule","volume":"108","author":"Kritmetapak","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lacerda-Abreu, M.A., Russo-Abrah\u00e3o, T., Rocco-Machado, N., Cosentino-Gomes, D., Dick, C.F., Carvalho-Kelly, L.F., Cunha Nascimento, M.T., Rocha-Vieira, T.C., and Meyer-Fernandes, J.R. (2021). Hydrogen Peroxide Generation as an Underlying Response to High Extracellular Inorganic Phosphate (Pi) in Breast Cancer Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810096"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3892\/ijo.2025.5758","article-title":"Molecular targets and therapies associated with poor prognosis of triple-negative breast cancer (Review)","volume":"66","author":"Kim","year":"2025","journal-title":"Int. J. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/PPO.0000000000000498","article-title":"Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy","volume":"27","author":"Marra","year":"2021","journal-title":"Cancer J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5603\/ocp.96485","article-title":"Systemic treatment in triple-negative breast cancer patients\u2014standard and novel approaches","volume":"20","author":"Potemski","year":"2024","journal-title":"Oncol. Clin. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"B\u0142aszczak, E., Miziak, P., Odrzywolski, A., Baran, M., Gumbarewicz, E., and Stepulak, A. (2025). Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial-Mesenchymal Transition. Cancers, 17.","DOI":"10.3390\/cancers17020228"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Nedeljkovi\u0107, M., and Damjanovi\u0107, A. (2019). Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge. Cells, 8.","DOI":"10.3390\/cells8090957"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/acs.chemrestox.6b00389","article-title":"Mass Spectrometry Based Proteomics Study of Cisplatin-Induced DNA-Protein Cross-Linking in Human Fibrosarcoma (HT1080) Cells","volume":"30","author":"Ming","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"02015","DOI":"10.1051\/e3sconf\/202458802015","article-title":"Application of cisplatin and other platinum-containing drugs in cancer therapy: Comprehensive review","volume":"588","author":"Prishya","year":"2024","journal-title":"E3S Web Conf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"108642","DOI":"10.1016\/j.pharmthera.2024.108642","article-title":"Cisplatin in the era of PARP inhibitors and immunotherapy","volume":"258","author":"Duan","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/jcp.24329","article-title":"RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis","volume":"228","author":"Tesoriere","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/1566524020666210104113003","article-title":"The Role of Retinoblastoma Protein in Cell Cycle Regulation: An Updated Review","volume":"21","author":"Roufayel","year":"2021","journal-title":"Curr. Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Moreno, E., Pandit, S.K., Toussaint, M.J.M., Bongiovanni, L., Harkema, L., van Essen, S.C., van Liere, E.A., Westendorp, B., and de Bruin, A. (2021). Atypical E2Fs either Counteract or Cooperate with RB during Tumorigenesis Depending on Tissue Context. Cancers, 13.","DOI":"10.3390\/cancers13092033"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.3390\/ijms130910697","article-title":"Cell signaling through protein kinase C oxidation and activation","volume":"13","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41419-019-2081-4","article-title":"Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells","volume":"10","author":"Kleih","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Marullo, R., Werner, E., Degtyareva, N., Moore, B., Altavilla, G., Ramalingam, S.S., and Doetsch, P.W. (2013). Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081162"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Weng, H.-C., Sung, C.-J., Hsu, J.-L., Leu, W.-J., Guh, J.-H., Kung, F.-L., and Hsu, L.-C. (2022). The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt\/mTOR and MAPK Signaling Pathways. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.879748"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cbin.12095","article-title":"Elevated extracellular inorganic phosphate inhibits ecto-phosphatase activity in breast cancer cells: Regulation by hydrogen peroxide","volume":"48","year":"2024","journal-title":"Cell Biol. Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00223-020-00686-3","article-title":"Phosphate Metabolism in Health and Disease","volume":"108","author":"Peacock","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mendelsohn Aviv, H., Yang, Z., and Jia, Z. (2026). Inorganic Polyphosphate in Mammals: Mechanisms, Maladies, and Moving Forward. Biomolecules, 16.","DOI":"10.3390\/biom16010127"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbcan.2018.05.001","article-title":"Inorganic phosphate transporters in cancer: Functions, molecular mechanisms and possible clinical applications","volume":"1870","author":"Monteiro","year":"2018","journal-title":"Biochim. ET. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"ref_41","first-page":"2180","article-title":"H+-dependent inorganic phosphate transporter in breast cancer cells: Possible functions in the tumor microenvironment","volume":"1865","author":"Nascimento","year":"2019","journal-title":"Biochim. ET. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/cbin.11497","article-title":"Ectophosphatase activity in the triple-negative breast cancer cell line MDA-MB-231","volume":"45","author":"Monteiro","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MNH.0000000000000984","article-title":"Phosphate sensing in health and disease","volume":"33","author":"Zechner","year":"2024","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000346776","article-title":"Extracellular phosphate as a signaling molecule","volume":"180","author":"Michigami","year":"2013","journal-title":"Contrib. Nephrol."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/8\/839\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:13:35Z","timestamp":1787285615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/8\/839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cimb48080839"],"URL":"https:\/\/doi.org\/10.3390\/cimb48080839","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}